![]() |
|
|
Vol. 296, Issue 2, 551-557, February 2001
Department of Pharmaceutical Sciences, University of Nebraska
Medical Center, Omaha, Nebraska (E.V.B., D.W.M., S.L., A.V.K., W.F.E.);
and Supratek Pharma Inc., Laval, Quebec, Canada (V.Y.A.)
Drug delivery across the blood-brain barrier is limited by several
mechanisms. One important mechanism is drug efflux, mediated by several
transport proteins, including P-glycoprotein. The goal of this work was
to examine the effect of a novel drug delivery system, Pluronic block
copolymer P85, on P-glycoprotein-mediated efflux from the brain using
in vitro and in vivo methods. The hypothesis was that specific Pluronic
copolymer systems enhance drug delivery to the central nervous system
through the inhibition of P-glycoprotein. The effect of P85 on the
cellular accumulation and transport of digoxin, a model P-glycoprotein
substrate, was examined in porcine kidney epithelial cells (LLC-PK1)
transfected with the human MDR1 gene. The effect of P85 on the
directional flux across an in vitro BBB was also characterized. In vivo
brain distribution studies were accomplished using wild-type and
P-glycoprotein knockout mice. Pluronic increased the cellular
accumulation of digoxin 3-fold in LLC-PK1 cells and 5-fold in the
LLC-PK1-MDR1-transfected cells. Similar effects were observed for a
prototypical P-glycoprotein substrate rhodamine-123. P85
treatment decreased the basolateral-to-apical and increased the
apical-to-basolateral digoxin flux across LLC-PK1-MDR1 cell monolayers,
and analogous results were observed with the in vitro BBB monolayers.
The coadministration of 1% P85 with radiolabeled digoxin in wild-type
mice increased the brain penetration of digoxin 3-fold and the digoxin
level in the P85-treated wild-type mice was similar to that observed in
the P-glycoprotein-deficient animals. These data indicate that Pluronic
P85 can enhance the delivery of digoxin to the brain through the
inhibition of the P-glycoprotein-mediated efflux mechanism.
This article has been cited by other articles:
![]() |
N. Giri, N. Shaik, G. Pan, T. Terasaki, C. Mukai, S. Kitagaki, N. Miyakoshi, and W. F. Elmquist Investigation of the Role of Breast Cancer Resistance Protein (Bcrp/Abcg2) on Pharmacokinetics and Central Nervous System Penetration of Abacavir and Zidovudine in the Mouse Drug Metab. Dispos., August 1, 2008; 36(8): 1476 - 1484. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamagata, H. Kusuhara, M. Morishita, K. Takayama, H. Benameur, and Y. Sugiyama Improvement of the Oral Drug Absorption of Topotecan through the Inhibition of Intestinal Xenobiotic Efflux Transporter, Breast Cancer Resistance Protein, by Excipients Drug Metab. Dispos., July 1, 2007; 35(7): 1142 - 1148. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Gebhart and A. V. Kabanov Perspectives on Polymeric Gene Delivery Journal of Bioactive and Compatible Polymers, March 1, 2003; 18(2): 147 - 166. [Abstract] [PDF] |
||||
![]() |
K. A. Witt, J. D. Huber, R. D. Egleton, and T. P. Davis Pluronic P85 Block Copolymer Enhances Opioid Peptide Analgesia J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 760 - 767. [Abstract] [Full Text] [PDF] |
||||